Search…

Ascentage Pharma (06855.HK): Trustee purchases 200,000 shares under the 2022 Restricted Share Unit Scheme

22/10/2026

Zhitong Finance APP news, Ascentage Pharma (06855.HK) announced that on October 22, 2026, the trustee purchased a total of 200,000 existing shares on-market for the purpose of the 2022 Restricted Share Unit Scheme to satisfy Restricted Share Units upon vesting.

Latest

2 m ago

IBM (IBM.US) pours cold water on Q4, sparking a bull-bear debate: Is it a "one-time catch-up" of deferred orders, or the starting point of a trend in its software transformation?

2 m ago

Hithink RoyalFlush (300033.SZ) released its first three quarters performance, with net profit attributable to shareholders of RMB 2.037 billion, up 68.86% year on year.

3 m ago

Senhao Group (08285): Controlling stake to change hands; receives mandatory general offer at approximately 34.9% premium; trading to resume on October 23.

4 m ago

Joulwatt Technology (688368.SH) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 251 million, a year-on-year increase of 977.18%.

6 m ago

Xingyun Technology (300209.SZ) released its first three quarters performance, with a net profit attributable to the parent company of 269 million yuan, turning a profit year-on-year.

See all latest